Innate Pharma earnings per share and revenue

IPHYF earnings per share for the last semiannual are -0.13 USD whereas the estimation was -0.45 USD which accounts for 70.25% surprise. Company revenue for the same period amounts to 23.64 M USD despite the estimated figure of 18.57 M USD. Estimated earnings per share for the next semiannual are -0.38 USD, and revenue is expected to reach 8.86 M USD. Also watch annual changes over time to get a bigger picture of IPHYF earnings per share and revenue dynamics.